Han­soh grabs $1B wind­fall in the lat­est Chi­na phar­ma IPO to hit the Hong Kong ex­change

Chi­na’s fast-grow­ing phar­ma pow­er­house Han­soh Phar­ma­ceu­ti­cal has raised a bil­lion dol­lars in the lat­est IPO to hit the Hong Kong ex­change. And the green shoe could push that up to $1.15 bil­lion, ac­cord­ing to the Fi­nan­cial Times.

The fi­nan­cial news group re­port­ed that Han­soh hit the top of its range, sell­ing 551 mil­lion shares at $1.82 each. Rough­ly half of that wind­fall will go to R&D, with the oth­er half ear­marked for their man­u­fac­tur­ing, sales and mar­ket­ing or­ga­ni­za­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.